title: Extensive toxic epidermal necrolysis following brentuximab vedotin administration.
authors: Istituto di Ematologia, Dipartimento di Biomedicina e Prevenzione, Università Tor Vergata, Viale Oxford 81, 00133, Rome, Italy, del.principe@med.uniroma2.it.
authors: Maria Ilaria
authors: MI
authors: Del Principe
authors: Giuseppe
authors: G
authors: Sconocchia
authors: Francesco
authors: F
authors: Buccisano
authors: Mariagiovanna
authors: M
authors: Cefalo
authors: Ambra
authors: A
authors: Di Veroli
authors: Giovanna
authors: G
authors: De Santis
authors: Daniela
authors: D
authors: Nasso
authors: Luca
authors: L
authors: Maurillo
authors: Lucia
authors: L
authors: Anemona
authors: Massimiliano
authors: M
authors: Postorino
authors: Giovanni
authors: G
authors: Del Poeta
authors: Sergio
authors: S
authors: Amadori
authors: Adriano
authors: A
authors: Venditti
mesh_terms: D000079963:Brentuximab Vedotin; D003937:Diagnosis, Differential; D006801:Humans; D018796:Immunoconjugates / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D012867:Skin / Q000187:drug effects* / Q000473:pathology; D013262:Stevens-Johnson Syndrome / Q000175:diagnosis* / Q000209:etiology; D055815:Young Adult
chemical_list: D018796:Immunoconjugates; D000079963:Brentuximab Vedotin